Cargando…
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
INTRODUCTION: Lurasidone is an atypical antipsychotic that was approved in Europe in 2014 for the treatment of schizophrenia in adults aged ≥ 18 years. Clinical experience with lurasidone in Europe is currently limited, and there is therefore a need to provide practical guidance on using lurasidone...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858892/ https://www.ncbi.nlm.nih.gov/pubmed/31098889 http://dx.doi.org/10.1007/s40120-019-0138-z |